HomeNewscoronavirusMaharashtra COVID-19 update | Nashik falls under level-2 of 'unlock', malls to reopen from June 21

Maharashtra COVID-19 update | Nashik falls under level-2 of 'unlock', malls to reopen from June 21

The malls in Nasik will be allowed to operate from 7 am to 4 pm on Monday to Friday.

June 19, 2021 / 17:16 IST
Story continues below Advertisement
Representative image
Representative image

With Nashik district in Maharashtra falling under the level-2 category of the five-level 'unlock' plan of the Maharashtra government, the local administration has decided to allow the reopening of malls with a 50 per cent capacity on weekdays from June 21, district guardian minister Chhagan Bhujbal said on Saturday. However, the administration has decided to continue with the level-3 restrictions considering the previous experience of crowding and various other factors.

The malls will be allowed to operate from 7 am to 4 pm on Monday to Friday. "RT-PCR test and anti-COVID 19 vaccination is made mandatory for all the employees of these malls as soon as possible. Use of a face mask, sanitiser, maintaining a social distance and thermal scanning is also a must for employees and customers," district collector Suraj Mandhare said in an order.

Story continues below Advertisement

COVID-19: Maharashtra reports 9,798 fresh cases, 198 deaths

As per the order, the COVID-19 positivity rate in the Nashik Municipal Corporation (NMC) areas and the rest of the district stood at 4.39 per cent and 9.03 per cent of the total oxygen beds remained occupied during the June 11 to 17 week. As a result, Nashik district is eligible for level-2 of the five-level unlock plan of the Maharashtra government.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show